NO20062044L - Piscirickettsia salmonis-antigener og anvendelse derav - Google Patents

Piscirickettsia salmonis-antigener og anvendelse derav

Info

Publication number
NO20062044L
NO20062044L NO20062044A NO20062044A NO20062044L NO 20062044 L NO20062044 L NO 20062044L NO 20062044 A NO20062044 A NO 20062044A NO 20062044 A NO20062044 A NO 20062044A NO 20062044 L NO20062044 L NO 20062044L
Authority
NO
Norway
Prior art keywords
present
srs
vaccines
antigens
proteins
Prior art date
Application number
NO20062044A
Other languages
English (en)
Other versions
NO341223B1 (no
Inventor
Michel Thiry
Ingrid Dheur
Original Assignee
Ingrid Dheur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430665&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20062044(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ingrid Dheur filed Critical Ingrid Dheur
Publication of NO20062044L publication Critical patent/NO20062044L/no
Publication of NO341223B1 publication Critical patent/NO341223B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Paper (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)

Abstract

Den foreliggende oppfinnelse bringer for dagen hittil ukjente proteiner, for eksempel, antigener, fra Piscirickettsia salmonis. Den foreliggende oppfinnelse bringer videre for dagen nukleinsyrer som koder for disse proteinene. Den foreliggende oppfinnelse bringer også for dagen anvendelse av proteinene, for eksempel, antigener, og nukleinsyrer for å fremstille vaksiner mot salmonid rickettsial septikemi (SRS). Den foreliggende oppfinnelse bringer videre tilveie rekombinante Yersinia ruckeri-celler som anvendes for å konstruere vaksiner mot SRS. Den foreliggende oppfinnelse bringer også for dagen vaksiner som kan anvendes for å beskytte fisk fra Piscirickettsia salmonis, så vel som andre patogener. I tillegg bringer den foreliggende oppfinnelse for dagen fremgangsmåter for å anvende vaksinene i henhold til den foreliggende oppfinnelse for å beskytte fisk mot SRS, så vel som mot andre patogene sykdommer.
NO20062044A 2003-10-07 2006-05-08 Piscirickettsia salmonis-antigener og anvendelse derav NO341223B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE20030743 2003-10-07
PCT/IB2004/003339 WO2005035558A2 (en) 2003-10-07 2004-10-01 Piscirickettsia salmonis antigens and use thereof

Publications (2)

Publication Number Publication Date
NO20062044L true NO20062044L (no) 2006-07-07
NO341223B1 NO341223B1 (no) 2017-09-18

Family

ID=34430665

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062044A NO341223B1 (no) 2003-10-07 2006-05-08 Piscirickettsia salmonis-antigener og anvendelse derav

Country Status (9)

Country Link
US (1) US7754223B2 (no)
EP (1) EP1670818B1 (no)
AT (1) ATE473236T1 (no)
AU (1) AU2004279610B2 (no)
CA (1) CA2541464C (no)
DE (1) DE602004028029D1 (no)
DK (1) DK177141B1 (no)
NO (1) NO341223B1 (no)
WO (1) WO2005035558A2 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006037383A1 (en) * 2004-10-01 2006-04-13 Michel Thiry Piscirickettsia salmonis antigens and use thereof
WO2007079147A2 (en) 2005-12-28 2007-07-12 Advanced Bionutrition Corporation A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
DE102007004303A1 (de) * 2006-08-04 2008-02-07 Osram Opto Semiconductors Gmbh Dünnfilm-Halbleiterbauelement und Bauelement-Verbund
EP2117354B1 (en) 2006-12-18 2018-08-08 Advanced BioNutrition Corp. A dry food product containing live probiotic
DE102007004304A1 (de) * 2007-01-29 2008-07-31 Osram Opto Semiconductors Gmbh Dünnfilm-Leuchtdioden-Chip und Verfahren zur Herstellung eines Dünnfilm-Leuchtdioden-Chips
CA2708167C (en) * 2007-12-19 2016-11-29 David Francis Kirke Vaccine antigens from piscirickettsia salmonis
US20100330113A1 (en) * 2007-12-19 2010-12-30 Intervet International B.V. Vaccine Antigens
WO2010111565A2 (en) * 2009-03-27 2010-09-30 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
EP2435554B1 (en) 2009-05-26 2017-07-26 Advanced Bionutrition Corporation Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
PL2529004T3 (pl) 2010-01-28 2017-12-29 Advanced Bionutrition Corporation Sucha szklista kompozycja zawierająca bioaktywny materiał
NO20100454A1 (no) * 2010-03-26 2011-09-27 Ewos Innovation As Forbindelse og sammensetning for kontroll av bakterier og virus
AR082682A1 (es) 2010-08-13 2012-12-26 Advanced Bionutrition Corp Composicion estabilizadora de almacenamiento en seco para materiales biologicos
US8420072B2 (en) * 2011-03-24 2013-04-16 The United States Of America, As Represented By The Secretary Of Agriculture Vaccination of sex reversed hybrid tilapia (Oreochromis niloticus x O. aureus) with an inactivated Vibrio vulnificus vaccine
WO2013084169A2 (en) * 2011-12-07 2013-06-13 Yanez Carcamo Alejandro Javier Novel broth medium and blood-free solid media for the culture of the fish pathogen piscirickettsia salmonis
WO2015071769A2 (en) * 2013-11-13 2015-05-21 University Of Oslo Outer membrane vesicles and uses thereof
MY194231A (en) 2015-07-29 2022-11-23 Advanced Bionutrition Corp Stable dry probiotic compositions for special dietary uses
US12558395B2 (en) 2015-07-29 2026-02-24 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
CL2017003358A1 (es) * 2017-12-26 2018-06-22 Univ De Chile 50% Formulación de vacuna para peces en base a nanovesículas lipídicas, en especial, un proteoliposoma o cocleato, con actividad contra el síndrome rickettsial del salmón

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165925A (en) * 1989-05-02 1992-11-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Vaccine for immunizing fish against infectious pancreatic necrosis virus
PT712926E (pt) 1994-10-18 2004-02-27 Akzo Nobel Nv Virus da doenca pancreatica do peixe
US20040086524A1 (en) * 1999-09-17 2004-05-06 Kuzyk Michael A. Vaccines and agents for inducing immunity in fish against rickettsial diseases, and associated preventative therapy
WO2001049712A2 (en) 2000-01-07 2001-07-12 Akzo Nobel N.V. Vaccine against isav (infectious salmon anaemia virus)
AU2001240791A1 (en) 2000-03-11 2001-09-24 Novartis Ag Sequence
EP1311675B1 (en) * 2000-08-22 2007-02-07 Agensys, Inc. Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
CA2428027C (en) 2000-11-11 2012-09-11 The University Court Of The University Of Aberdeen Yeast derived vaccine against ipnv
CA2381708C (en) * 2001-08-27 2011-10-18 Universidad Catolica De Valparaiso Immunogenic protein against piscirickettsia salmonis

Also Published As

Publication number Publication date
WO2005035558A3 (en) 2005-10-13
DK177141B1 (da) 2012-02-06
WO2005035558A2 (en) 2005-04-21
DK200600643A (da) 2006-05-05
AU2004279610B2 (en) 2010-02-25
EP1670818A2 (en) 2006-06-21
US7754223B2 (en) 2010-07-13
DE602004028029D1 (en) 2010-08-19
EP1670818B1 (en) 2010-07-07
ATE473236T1 (de) 2010-07-15
CA2541464C (en) 2016-02-09
CA2541464A1 (en) 2005-04-21
AU2004279610A1 (en) 2005-04-21
US20070207165A1 (en) 2007-09-06
NO341223B1 (no) 2017-09-18

Similar Documents

Publication Publication Date Title
NO20062044L (no) Piscirickettsia salmonis-antigener og anvendelse derav
CY1122505T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
WO2019193183A3 (en) Novel yellow fever nucleic acid molecules for vaccination
NO20091665L (no) Tumorassosierte antigenderivater fra MAGE-familien, og nuklinsyresekvenser som koder for disse, anvendt for fremstilling av fusjonsproteiner og for vaksinesammensetninger
CY1121353T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
NO20081043L (no) Vaksine for fisk
WO2009077577A3 (en) Vaccine antigens from piscirickettsia salmonis
ECSP077888A (es) Anticuerpos anti-il-6, composiciones, metodos y usos
NO20071609L (no) Immunogen sammensetning for anvendelse ved vaksinering mot stafylokokker
UY26783A1 (es) Antígenos de estreptococo.
EP1917033A4 (en) VIRUS LIKE PARTICLES AS PARAMYXOVIRUS VACCINES
PE20060816A1 (es) Proceso para la concentracion de anticuerpos y productos terapeuticos de los mismos
MY206284A (en) Anti-cd63 antibodies, conjugates, and uses thereof
EA200401504A1 (ru) Слитый белок из числа регуляторных/вспомогательных белков вич
EA200701305A1 (ru) Иммуногенные композиции, содержащие циклические пептиды, полученные из бета-амилоидного пептида
JP2020523001A5 (no)
EA200970731A1 (ru) Рекомбинантные антигены цитомегаловируса человека (hcmv)
ATE520708T1 (de) Immunogenetische hiv-1 multi-klade, multivalente konstrukte und deren verwendung
CN109593765A (zh) CpG寡脱氧核苷酸、免疫组成物及其用途
NO20053328L (no) Immunisering av fisk med uttrykte proteiner i planteceller.
ATE450545T1 (de) Impfstoff mit lawsonia intracellularis- untereinheit
DK1334197T3 (da) Gær-afledt vaccine mod IPNV
NO20020615L (no) Vaksine
MX2024005962A (es) Composiciones de proteínas de fusión inmunogénicas y métodos de uso de estas
Manjunathachar et al. Expression and determination of immunization dose of recombinant tropomyosin protein of Hyalomma anatolicum for the development of anti-tick vaccine

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees